NasdaqGS - Delayed Quote USD

Healthcare Services Group, Inc. (HCSG)

11.22 -0.73 (-6.11%)
At close: April 24 at 4:00 PM EDT
11.26 +0.04 (+0.36%)
After hours: April 24 at 7:23 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 5555
Avg. Estimate 0.190.190.780.85
Low Estimate 0.170.180.750.8
High Estimate 0.210.210.830.93
Year Ago EPS 0.170.120.520.78

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 5555
Avg. Estimate 424.95M430.42M1.73B1.79B
Low Estimate 423.58M429M1.73B1.76B
High Estimate 426.18M432.05M1.74B1.8B
Year Ago Sales 417.23M418.93M1.67B1.73B
Sales Growth (year/est) 1.90%2.70%3.50%3.30%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 0.130.170.180.16
EPS Actual 0.170.12-0.070.31
Difference 0.04-0.05-0.250.15
Surprise % 30.80%-29.40%-138.90%93.80%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.190.190.780.85
7 Days Ago 0.190.190.780.85
30 Days Ago 0.190.190.780.85
60 Days Ago 0.190.20.80.86
90 Days Ago 0.170.170.720.71

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD HCSGIndustrySectorS&P 500
Current Qtr. 11.80%----1.50%
Next Qtr. 58.30%----11.40%
Current Year 50.00%----5.20%
Next Year 9.00%----13.40%
Next 5 Years (per annum) 9.00%----11.09%
Past 5 Years (per annum) -21.12%------

Research Analysis

Analyst Price Targets

13.00
14.50 Average
11.22 Current
17.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains Benchmark: Buy to Buy 2/15/2024
Maintains UBS: Neutral to Neutral 2/15/2024
Maintains Baird: Neutral to Neutral 2/15/2024
Maintains RBC Capital: Outperform to Outperform 2/15/2024
Reiterates Benchmark: Buy to Buy 12/22/2023
Initiated UBS: Neutral 11/30/2023

Related Tickers